CYC065-eribulin combination for triple-negative breast cancer identified
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
List view / Grid view
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
7 March 2016 | By Victoria White
The Scottish Medicines Consortium (SMC) has accepted three new medicines for routine use in NHS Scotland.